OTCQX:MRVFF - Post by User
Post by
blackascanbeon Aug 26, 2010 12:33pm
389 Views
Post# 17386236
consultant 99
consultant 99I guess you and I could argue all day and you will see the glass half empty while I see it half full. Did you ever think that Covidien is doing phase 2 trials in order to get Pennsaid gel approved for joints other than just the knees? Would a delay of 6 months not be worth that? How do you know that Pennsaid isn't selling 10's of millions of dollars worth right now? If you look at the most independent assessment of Pennsaid that we have right now, that is the one from Covidien themselves, clearly having invested at least 100 million in up front payments, sales training, and future development costs of Pennsaid gel, they see value in the Pennsaid/Nuvo franchise that goes well beyond the total market cap of Nuvo right now. You as well as most everyone else on this board is letting the current ridiculously low share price affect you emotionally. Try and keep your head and focus on what the company is doing and not what the share price is. Trust me, it will be getting alot better soon.